You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
柳藥股份(603368.SH)擬出資2500萬元參設合資公司 拓展高品質醫學影像設備產業
格隆匯 07-28 16:46

格隆匯7月28日丨柳藥股份(603368.SH)公吿,在國家政策推動大型醫療設備國產化趨勢下,為加強醫療設備產品生產、研發及銷售業務的合作,基於對雙方發展優勢與服務優勢資源的認同,公司與上海康達卡勒幅醫療科技股份有限公司(簡稱“上海康達卡勒幅”)於2021年7月28日簽署了《合資經營協議》,擬共同投資設立廣西康達卡勒幅醫療科技有限公司(暫定名,最終以登記機關核准的名稱為準,簡稱目標公司)。目標公司註冊資本為人民幣5,000萬元,公司以自有資金出資2,500萬元,佔目標公司註冊資本的50%,上海康達卡勒幅以自有資金出資2,500萬元,佔目標公司註冊資本的50%。

公司與上海康達卡勒幅共同投資設立目標公司,有利於充分發揮雙方在各自領域的優勢,憑藉公司在藥械管理、物流配送及中高端醫療機構的客户資源優勢,上海康達卡勒幅在國產高端醫學影像產品的研發、製造、銷售與服務的突出優勢,在國家政策支持和鼓勵國產高端醫療設備替代進口設備的大背景下,共同拓展廣西乃至全國、面向東盟出口的高品質醫學影像設備產業。

本次合作有助於進一步拓展公司的業務範圍,助力提升公司研發能力,拓展產業佈局,並培養新的利潤增長點,形成醫藥商品和服務集聚經營產品鏈,提升公司市場競爭力和未來盈利能力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account